Revenue (Annual) Chart

Historical Revenue (Annual) Data

View and export this data back to 1992. Start Trial.
Date Value
December 31, 2025 9.443M
December 31, 2024 10.91M
December 31, 2023 10.02M
December 31, 2022 10.16M
December 31, 2021 10.65M
December 31, 2020 10.84M
December 31, 2019 10.00M
December 31, 2018 10.43M
December 31, 2017 9.898M
December 31, 2016 7.527M
December 31, 2015 7.878M
December 31, 2014 9.844M
December 31, 2013 15.00M
December 31, 2012 16.97M
December 31, 2011 14.76M
December 31, 2010 16.00M
December 31, 2009 8.590M
Date Value
December 31, 2008 8.367M
December 31, 2007 16.39M
December 31, 2006 14.94M
December 31, 2005 6.002M
December 31, 2004 4.953M
December 31, 2003 11.05M
December 31, 2002 18.39M
December 31, 2001 1.087M
December 31, 2000 1.024M
December 31, 1999 3.212M
December 31, 1998 10.43M
December 31, 1997 13.09M
December 31, 1996 21.16M
September 30, 1995 13.23M
September 30, 1994 5.807M
September 30, 1993 2.654M
September 30, 1992 5.002M

Revenues Definition

Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.

Read full definition.

Revenue (Annual) Range, Past 5 Years

View Revenue (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue (Annual) Benchmarks

View Revenue (Annual) Benchmarks
Start Trial
Agenus, Inc. 114.20M
Amgen, Inc. 36.74B
BioCryst Pharmaceuticals, Inc. 874.84M
Imunon, Inc. 0.00
CEL-SCI Corp. 0.00